Prognosis of Prehypertension Without Progression to Hypertension

Affiliations

¹ From National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (T.J.N., M.G.L., V.X., R.S.V., S.C.); Department of Biostatistics (M.G.L., V.X.), Department of Medicine, Section of Preventive Medicine (R.S.V.), Department of Medicine, Section of Cardiology (R.S.V.), and Department of Epidemiology (R.S.V.), Boston University School of Public Health, MA; and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (E.L.M., S.C.). teemu.niiranen@thl.fi.
² From National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (T.J.N., M.G.L., V.X., R.S.V., S.C.); Department of Biostatistics (M.G.L., V.X.), Department of Medicine, Section of Preventive Medicine (R.S.V.), Department of Medicine, Section of Cardiology (R.S.V.), and Department of Epidemiology (R.S.V.), Boston University School of Public Health, MA; and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (E.L.M., S.C.).

Observational Study

Teemu J Niiranen et al. Circulation. 2017.

. 2017 Sep 26;136(13):1262-1264.

doi: 10.1161/CIRCULATIONAHA.117.029317.

¹ From National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (T.J.N., M.G.L., V.X., R.S.V., S.C.); Department of Biostatistics (M.G.L., V.X.), Department of Medicine, Section of Preventive Medicine (R.S.V.), Department of Medicine, Section of Cardiology (R.S.V.), and Department of Epidemiology (R.S.V.), Boston University School of Public Health, MA; and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (E.L.M., S.C.). teemu.niiranen@thl.fi.
² From National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (T.J.N., M.G.L., V.X., R.S.V., S.C.); Department of Biostatistics (M.G.L., V.X.), Department of Medicine, Section of Preventive Medicine (R.S.V.), Department of Medicine, Section of Cardiology (R.S.V.), and Department of Epidemiology (R.S.V.), Boston University School of Public Health, MA; and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (E.L.M., S.C.).

No abstract available

Keywords: cardiovascular diseases; epidemiology; hypertension; mortality; prevention.

Figures

1. Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291–1297. doi: 10.1056/NEJMoa003417. - DOI - PubMed
1. Egan BM, Stevens-Fabry S. Prehypertension--prevalence, health risks, and management strategies. Nat Rev Cardiol. 2015;12:289–300. doi: 10.1038/nrcardio.2015.17. - DOI - PubMed
1. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358:1682–1686. - PubMed
1. Tsao CW, Vasan RS. Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol. 2015;44:1800–1801. doi: 10.1093/ije/dyv337. - DOI - PMC - PubMed
1. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend RR, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) 2014;16:14–26. doi: 10.1111/jch.12237. - DOI - PMC - PubMed